Papers
3
Total Citations
17
H-Index
2
About
Toru Yamada is a leading figure in urologic oncology, with a focused expertise in robot-assisted radical prostatectomy (RARP) for advanced and metastatic prostate cancer. His research has been instrumental in redefining the role of surgical intervention beyond early-stage disease, particularly exploring cytoreductive prostatectomy for patients with metastatic prostate cancer (mPCa). Yamada’s most cited work (2022, 9 citations) provides compelling evidence that RARP may improve oncological outcomes in this challenging population, challenging traditional treatment paradigms. He has also contributed critical insights into postoperative management, including a notable case study on delayed lymphocele infection six months post-RARP (2017, 6 citations), highlighting the need for vigilance in nonspecific symptoms. Further expanding the surgical frontier, his work on oligometastatic castration-resistant prostate cancer (2020, 2 citations) demonstrates the potential benefits of local definitive therapy in low-volume osseous metastases. With a cumulative impact of 17 citations across his key papers, Yamada’s research is shaping surgical strategies for high-risk prostate cancer, offering new hope for patients with advanced disease. His dedication to refining robotic techniques and managing complex complications marks him as a pioneer in the field.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3